Myelodysplastic syndromes are multiclonal diseases derived from hematopoietic stem and progenitor cells

Myelodysplastic syndromes (MDS) are generally considered as a group of clonal diseases derived from hematopoietic stem cells, but a number of studies have suggested that they are derived from myeloid progenitor cells. We aimed to identify the cell of origin in MDS by single-cell analyses. Targeted s...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Bingqing, Dong, Fang, Qin, Tiejun, Zhang, Qingyun, Bai, Haitao, Wang, Jinhong, Jia, Yujiao, Ma, Shihui, Jiang, Erlie, Cheng, Tao, Xiao, Zhijian, Ema, Hideo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109331/
https://www.ncbi.nlm.nih.gov/pubmed/35578364
http://dx.doi.org/10.1186/s40164-022-00280-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109331/
https://www.ncbi.nlm.nih.gov/pubmed/35578364
http://dx.doi.org/10.1186/s40164-022-00280-3

Ejemplares similares